Statins: A Potential Therapeutic Addition to Treatment for Aneurysmal Subarachnoid Hemorrhage? (Q37799035)

23 August 2017

title

Statins: a potential therapeutic addition to treatment for aneurysmal subarachnoid hemorrhage? (English)

1 reference

23 August 2017

Statins: A Potential Therapeutic Addition to Treatment for Aneurysmal Subarachnoid Hemorrhage? (English)

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2010.03.032

30 July 2024

author name string

Mohammed Sabri

1

1 reference

23 August 2017

R. Loch Macdonald

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20934152

30 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20934152

30 July 2024

publication date

1 June 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S1878875010001567?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2010.03.032

https://api.elsevier.com/content/article/PII:S1878875010001567?httpAccept=text/plain

30 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2010.03.032

30 July 2024

1 reference

23 August 2017

volume

73

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

646-653

1 reference

Simvastatin suppresses the progression of experimentally induced cerebral aneurysms in rats

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Receptor-Mediated Control of Cholesterol Metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Effect of combined simvastatin and cyclosporine compared with simvastatin alone on cerebral vasospasm after subarachnoid hemorrhage in a canine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Meta-analysis of statins for aneurysmal subarachnoid hemorrhage falls short

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Statin-drug interactions: not a class effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Inhibitory effects on lipid metabolism in cultured cells of ML-236B, a potent inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

A case control study of statin and magnesium administration in patients after aneurysmal subarachnoid hemorrhage: incidence of delayed cerebral ischemia and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Statins in the management of aneurysmal subarachnoid hemorrhage--not (yet) a standard of care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Statin therapy within the perioperative period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Pleiotropic effects of statins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

SLCO1B1 variants and statin-induced myopathy--a genomewide study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Effect of an inhibitor of 3-hydroxy-3-methyglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Prehemorrhage statin use and the risk of vasospasm after aneurysmal subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

The acute (cerebro)vascular effects of statins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Statins: mechanisms of neuroprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

Therapeutic effects of ML-236B in primary hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.03.032

The discovery and development of HMG-CoA reductase inhibitors

7 January 2021

7

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2010.03.032

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

30 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.WNEU.2010.03.032

30 July 2024

Identifiers

1 reference

23 August 2017

1 reference